Ehab I Taha
Overview
Explore the profile of Ehab I Taha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li K, Li D, Hafez B, Bekhit M, Bin Jardan Y, Alanazi F, et al.
Oncol Res
. 2024 Apr;
32(4):737-752.
PMID: 38560573
Kidney Renal Clear Cell Carcinoma (KIRC) is a malignant tumor that carries a substantial risk of morbidity and mortality. The MMP family assumes a crucial role in tumor invasion and...
2.
Mahmood T, Sarfraz R, Mahmood A, Salem-Bekhit M, Ijaz H, Zaman M, et al.
ACS Omega
. 2024 Mar;
9(9):10498-10516.
PMID: 38463273
The purpose of the current research is to formulate a smart drug delivery system for solubility enhancement and sustained release of hydrophobic drugs. Drug solubility-related challenges constitute a significant concern...
3.
Benakli Y, Khenchouche A, Rabea S, Mansour A, Salem-Bekhit M, Taha E, et al.
Cell Mol Biol (Noisy-le-grand)
. 2023 Dec;
69(13):217-224.
PMID: 38158662
Gastric cancer (GC) is a serious public health issue due to its frequency and severity. It is, for both sexes, one of the most common causes of cancer-related death and...
4.
Salem-Bekhit M, Riad O, Selim H, Tohamy S, Taha E, Al-Suwayeh S, et al.
Life (Basel)
. 2023 Aug;
13(8).
PMID: 37629525
Milk contaminated with aflatoxin can lead to liver cancer. Aflatoxin B1 (AFB1), a serious animal feed contaminant, is transformed into Aflatoxin M1 (AFM1) and secreted in milk. In this study,...
5.
Sherif A, Harisa G, Shahba A, Nasr F, Taha E, Alqahtani A
Drug Dev Res
. 2023 Jul;
84(7):1453-1467.
PMID: 37519092
Breast cancer represents a life-threatening problem globally. The major challenge in the clinical setting is the management of cancer resistance and metastasis. Hybrid therapy can affect several cellular targets involved...
6.
Khenchouche A, Salem-Bekhit M, Mansour A, Alomary M, Wang X, Alzahrani H, et al.
Microorganisms
. 2023 Jul;
11(7).
PMID: 37512884
The study aimed to investigate the antitumor efficacy of anti-LMP1 antibodies in EBV-positive nasopharyngeal and stomach cell lines and xenograft models. The study also examined the NF-κB expression and cell...
7.
Al-Suwayeh S, Badran M, Alhumoud G, Taha E, Ashri L, Kazi M
Saudi Pharm J
. 2023 May;
31(6):889-903.
PMID: 37228319
The present study aimed to evaluate the impact of ultrafine nanoemulsions on the transdermal delivery of lornoxicam (LOR) for management of the inflammation. The transdermal administration of LORNE could increase...
8.
Shafiq K, Mahmood A, Salem-Bekhit M, Sarfraz R, Algarni A, Taha E, et al.
Pharmaceuticals (Basel)
. 2022 Dec;
15(12).
PMID: 36558978
Acyclovir has a short half-life and offers poor bioavailability. Its daily dose is 200 mg five times a day. A tamarind gum and β-cyclodextrin-based pH-responsive hydrogel network for sustained delivery...
9.
Aleanizy F, Taha E, Salem-Bekhit M, Felimban A, Al-Suwayeh S, Al-Joufi F, et al.
Drug Dev Ind Pharm
. 2022 May;
47(12):1935-1942.
PMID: 35537065
Surfactant-stabilized mucoadhesive nanogels (NGs) for vaginal delivery of fluconazole (FLZ) were studied and evaluated in this work. FLZ-NG formulations were prepared using two different types of mucoadhesive polymers, Carbopol 934...
10.
Ahmad F, Salem-Bekhit M, Khan F, Alshehri S, Khan A, Ghoneim M, et al.
Nanomaterials (Basel)
. 2022 Apr;
12(8).
PMID: 35458041
This review tries to summarize the purpose of steadily developing surface-functionalized nanoparticles for various bio-applications and represents a fascinating and rapidly growing field of research. Due to their unique properties-such...